Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 7
Author(s): William Cho
Affiliation:
Export Options
About this article
Cite this article as:
Cho William , Meet Our Editorial Board Member, Current Cancer Drug Targets 2018; 18 (7) . https://dx.doi.org/10.2174/156800961807180731141433
DOI https://dx.doi.org/10.2174/156800961807180731141433 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
23
3
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Efficient <i>In Vitro</i> Refolding and Characterization of Major Histocompatibility Complex Class I-Related Chain Molecules A (MICA) and Natural Killer Group 2 Member D (NKG2D) Expressed in <i>E. coli</i>
Protein & Peptide Letters Bioactivation and Hepatotoxicity of Nitroaromatic Drugs
Current Drug Metabolism Biomarkers and Multiple Drug Resistance in Breast Cancer
Current Cancer Drug Targets Anti-Infective Quinone Derivatives of Recent Patents
Recent Patents on Anti-Infective Drug Discovery Reductive Cyclisation in the Synthesis of 5-Membered N-Heterocycles
Current Organic Chemistry Oxidation Inhibits Iron-Induced Blood Coagulation
Current Drug Targets Synthesis and Biochemical Evaluation of a Range of 4-(n-alkanesulfonate) benzyl Imidazole-Based Compounds as Inhibitors of Rat Testicular 17α-hydroxylase/17,20-lyase (P450<sub>17α</sub>) in the Treatment of Hormone- Dependent Prostate Cancer
Letters in Drug Design & Discovery Vascular Effects of Estrogenic Menopausal Hormone Therapy
Reviews on Recent Clinical Trials Editorial [Hot Topic: The Pineal Hormone Melatonin in Health and Disease (Guest Editors: Charanjit Kaur)]
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) The Evaluation of Multivariate Adaptive Regression Splines for the Prediction of Antitumor Activity of Acridinone Derivatives
Medicinal Chemistry Isolation of Antibodies From Non-Human Primates for Clinical Use
Current Drug Discovery Technologies Agonists of the Tissue-Protective Erythropoietin Receptor in the Treatment of Parkinson’s Disease
Current Topics in Medicinal Chemistry Amelioration of Cisplatin Induced Nephrotoxicity by Standardized Methanolic Extract of Roots of Boerhaavia diffusa
The Natural Products Journal Strategies to Improve the Functions and Redox State of the Immune System in Aged Subjects
Current Pharmaceutical Design Protein Targets for Anticancer Gold Compounds: Mechanistic Inferences
Anti-Cancer Agents in Medicinal Chemistry Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Current Genomics Skeletal Muscle Cell Behavior After Physical Agent Treatments
Current Pharmaceutical Design Second Generation Proteasome Inhibitors in Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Looking for New Inhibitors for the Epidermal Growth Factor Receptor
Current Topics in Medicinal Chemistry Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis
Current Pharmaceutical Design